NKY(SZ:300109) Sou Hu Cai Jing·2025-08-19 17:34Financial Performance - As of the closing on August 19, 2025, the company's stock price was 18.08 yuan, down 0.82% with a turnover rate of 3.76% and a trading volume of 169,100 hands, amounting to 305 million yuan in transaction value [1] - The latest quarterly report shows total revenue of 325 million yuan, a year-on-year decrease of 17.69%, and a net profit attributable to shareholders of 80.42 million yuan, down 33.75% year-on-year [1] - The company's non-recurring net profit was 69.42 million yuan, reflecting a year-on-year decrease of 44.85% [1] - The liquidity ratios are as follows: current ratio at 2.565, quick ratio at 2.016, and debt-to-asset ratio at 18.03% [1] Investment and Business Activities - The company has made investments in 19 enterprises and participated in 34 bidding projects [2] - It holds 56 trademark registrations and 56 patent registrations, along with 95 administrative licenses [2] Company Background - Founded in 2003, the company is based in Jiaozuo City and primarily engages in the pharmaceutical manufacturing industry [1] - The registered capital is approximately 4.86 billion yuan, with paid-in capital of about 4.85 billion yuan [1]